By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – XDx today said that Aetna has determined that the firm's AlloMap test is medically necessary for monitoring rejection in heart transplant recipients more than a year after a heart transplant.
Registering provides access to this and other free content.
Already have an account?Login Now.
Social media is changing how scientists discuss research, as tweets from University of Chicago's Yoav Gilad about a Mouse ENCODE paper have shown, Nature reports.
In Nature this week: factors affecting the success of whole-genome sequencing for routine clinical diagnosis, and more.
A large meta-analysis from an international team reports that nature and nurture have about an equal overall influence on human traits.
The Lasker Foundation's Claire Pomeroy laments the state of NIH funding at Forbes.